ILYX-002
Autoimmune-Associated Dry Eye Disease
Preclinical/Phase 1Active
Key Facts
Indication
Autoimmune-Associated Dry Eye Disease
Phase
Preclinical/Phase 1
Status
Active
Company
About Laboratoires Théa
Laboratoires Théa is a privately held, fully integrated ophthalmology company with a global commercial footprint and a vertically integrated '100% made in Europe' manufacturing model. Its core business is built on a portfolio of commercial products addressing common eye conditions like dry eye, glaucoma, allergies, and infections, while actively investing in a diversified R&D pipeline through internal development and strategic partnerships. The company is led by its founding family, emphasizes corporate social responsibility with a stated carbon neutrality goal by 2045, and is expanding its pipeline into novel therapeutic areas such as myopia progression and genetic retinal diseases.
View full company profile